Literature DB >> 24490550

[Comparative study on four major active compounds of Sanvitalia procumbens and Chrysanthemum morifolium cv 'Hangju' and 'Gongju'].

Liang Wang1, Tao Wang1, Qiao-Sheng Guo1, Yong Huang2, Hao-Kun Xu2.   

Abstract

The contents of chlorogenic acid, 3,5-O-caffeoylquinic acid, galuteolin and quercitrin in Sanvitalia procumbens and Chrysanthemum morifolium cv. 'Hangju' and 'Gongju' were determined by RP-HPLC. The main active ingredient of S. procumbens was similar to C. morifolium cv. 'Hangju' and 'Gongju'. The content varied significantly. The contents of chlorogenic acid, quercitrin and galuteolin in S. procumbens were 7.46, 46.58, 26.01 mg x g(-1), respectively, and they were the highest among the samples. The content of 3,5-O-caffeoylquinic acid in C. morifolium cv. 'Hangju' was 14.70 mg x g(-1), it was the highest among the samples. The data of the study provide a basis for further research and development of S. procumbens.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24490550

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  3 in total

1.  Affective Antidepressant, Cytotoxic Activities, and Characterization of Phyto-Assisted Zinc Oxide Nanoparticles Synthesized Using Sanvitalia procumbens Aqueous Extract.

Authors:  Yasir Rashid; Ijaz Ahmad; Nisar Ahmad; Madeeha Aslam; Amal Alotaibi
Journal:  Biomed Res Int       Date:  2022-06-16       Impact factor: 3.246

2.  Phyto-Extract-Mediated Synthesis of Silver Nanoparticles Using Aqueous Extract of Sanvitalia procumbens, and Characterization, Optimization and Photocatalytic Degradation of Azo Dyes Orange G and Direct Blue-15.

Authors:  Madeeha Aslam; Fozia Fozia; Anadil Gul; Ijaz Ahmad; Riaz Ullah; Ahmed Bari; Ramzi A Mothana; Hidayat Hussain
Journal:  Molecules       Date:  2021-10-12       Impact factor: 4.411

3.  Extraction of flavonoids from Chrysanthemum morifolium and antitumor activity in vitro.

Authors:  Ying-Hui Liu; Xin Mou; Di-Yi Zhou; Dan-Yang Zhou; Cheng-Min Shou
Journal:  Exp Ther Med       Date:  2017-11-27       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.